COL1A1 and pulmonary fibrosis: In a model of bleomycin-induced lung fibrosis in mice, dasatinib plus quercetin (5 mg·kg−1 and 50 mg·kg−1) orally for three days improved lung function in terms of exercise capacity, lung compliance and reduced lung fibrosis, and senescence markers, such as as IL-6, TNF-α, MMP-3, MMP-12, Col1A1, TGF-β, and MCP-1 [9].